MATTE', Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 1.595
EU - Europa 1.540
AS - Asia 571
SA - Sud America 10
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 3.726
Nazione #
US - Stati Uniti d'America 1.588
GB - Regno Unito 592
CN - Cina 450
IT - Italia 222
SE - Svezia 167
IE - Irlanda 141
FR - Francia 133
VN - Vietnam 99
DE - Germania 81
FI - Finlandia 76
RU - Federazione Russa 50
UA - Ucraina 34
BE - Belgio 15
NL - Olanda 6
IN - India 5
JP - Giappone 5
MX - Messico 5
BR - Brasile 4
TR - Turchia 4
AT - Austria 3
AU - Australia 3
CL - Cile 3
ES - Italia 3
GR - Grecia 3
HK - Hong Kong 3
NG - Nigeria 3
AR - Argentina 2
BA - Bosnia-Erzegovina 2
CA - Canada 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
EU - Europa 2
PL - Polonia 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CO - Colombia 1
DK - Danimarca 1
GH - Ghana 1
IR - Iran 1
KR - Corea 1
LI - Liechtenstein 1
LK - Sri Lanka 1
NO - Norvegia 1
RS - Serbia 1
SG - Singapore 1
UZ - Uzbekistan 1
Totale 3.726
Città #
Southend 538
Chandler 340
Jacksonville 187
Ann Arbor 154
Dublin 141
Verona 104
Beijing 95
Houston 83
Ashburn 81
Woodbridge 78
Wilmington 69
Dong Ket 57
Lawrence 50
Princeton 50
Jinan 47
New York 42
Nanjing 39
Hebei 32
Shenyang 31
Helsinki 24
Lancaster 19
Collegeville 18
Falls Church 18
Ningbo 18
Redmond 17
Sindelfingen 17
Changsha 16
Hangzhou 16
Nanchang 16
Zhengzhou 16
Brussels 15
Seattle 13
Guangzhou 12
Milan 12
Taiyuan 12
Tianjin 11
Haikou 10
Jiaxing 10
Taizhou 9
Chicago 7
Redwood City 7
Cagliari 6
Cambridge 6
Catanzaro 6
Lanzhou 6
Norwalk 6
San Francisco 6
Bologna 5
Fairfield 5
Fuzhou 5
Renton 5
Tacoma 5
Washington 5
Boardman 4
Chieti 4
Chions 4
Crotone 4
Dongguan 4
Sassari 4
Villiers-sur-marne 4
Camerino 3
Cincinnati 3
Cleveland 3
Groningen 3
Lagos 3
Munich 3
Puebla City 3
Shreveport 3
Vienna 3
Albany 2
Bangalore 2
Basel 2
Caderousse 2
Canberra 2
Changle 2
Clearwater 2
Cockeysville 2
Dallas 2
Ely 2
Foiano della Chiana 2
Fremont 2
Glasgow 2
Hong Kong 2
Itapira 2
Kochi 2
Lanciano 2
Los Angeles 2
Milwaukee 2
Monmouth Junction 2
Nashville 2
Ome 2
Othon P. Blanco 2
Paris 2
Río Cuarto 2
Saint Louis 2
Saint-Andre-des-Eaux 2
San Diego 2
Sarajevo 2
Stockholm 2
Toronto 2
Totale 2.714
Nome #
Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease 176
TREATMENT OF SKELETAL DISEASES WITH A NATURALLY DERIVED ANTIOXIDANT AND BISPHOSPHONATE EMBEDDED NANOPARTICLES 127
Two-photon microscopy imaging of thy1GFP-M transgenic mice: a novel animal model to investigate brain dendritic cell subsets in vivo 117
Protease inhibitors-based therapy induces acquired spherocytic-like anemia and ineffective erythropoiesis in chronic HCV patients 103
PEROXIREDOXIN-2: A NOVEL REGULATOR OF IRON HOMEOSTASIS IN INEFFECTIVE ERYTHROPOIESIS 100
Membrane association of peroxiredoxin-2 in red cells is mediated by the N-terminal cytoplasmic domain of band3 99
Integrated proteomic analysis of normal and diseased red cells. Role of physiological stresses in erythrocyte signaling pathways 94
Oxidative stress and b-thalasssemic erythroid cells behind the molecular defect 94
Impaired pro‐resolving mechanisms promote abnormal NETosis , fueling autoimmunity in sickle cell disease 91
Band 3 Erythrocyte Membrane Protein Acts as Redox Stress Sensor Leading to Its Phosphorylation by p (72) Syk 91
Pharmacological inhibition of calpain-1 prevents red cell dehydration and reduces Gardos channel activity in a mouse model of sickle cell disease 90
A Selective Oral GLYT1 Inhibitor, Improves Anemia and Red Cell Survival in a Mouse Model of Beta-Thalassemia 89
Resveratrol accelerates erythroid maturation by activation of FoxO3 and ameliorates anemia in beta-thalassemic mice 88
The interplay between peroxiredoxin-2 and Nrf2 is important in limiting oxidative mediated dysfunction in b-thalassemic erythropoiesis 88
S-nitrosylation of peroxiredoxin II E promotes peroxynitrite-mediated tyrosine nitration 85
Erythrocyte membrane changes of chorea-acanthocytosis are the result of altered Lyn kinase activity 83
Peroxiredoxin-2: A Novel Factor Involved in Iron Homeostasis 81
Heat shock protein-27, 70 and peroxiredoxin-II show molecular chaperone function in sickle red cells: evidences from transgenic sickle cell mouse model 79
IN ChAc RED CELLS THE ABNORMALLY ACTIVATED LYN AFFECTS ANKYRIN MULTIPROTEIN COMPLEXES AND IS INHIBITED BY DASATINIB 79
Deoxygenation affects tyrosine phosphoproteome of red cell membrane from patients with sickle cell disease 77
Resolution of sickle cell disease-associated inflammation and tissue damage with 17R-resolvin D1. 77
Dietary w-3 fatty acids protect against vasculopathy in a transgenic mouse model for sickle cell disease. 76
The novel role of peroxiredoxin-2 in red cell membrane protein homeostasis and senescence. 75
Factor H interfers with the adhesion of sickle red cells to vascular endothelium: a novel disease modulating molecule 75
A new molecular link between defective autophagy and erythroid abnormalities in chorea-acanthocytosis 74
Fyn kinase is a novel modulator of erythropoietin signaling and stress erythropoiesis. 74
Oxidized and poorly glycosylated band 3 is selectively phosphorylated by Syk kinase to form large membrane clusters in normal and G6PD-deficient red blood cells 72
Increased levels of ERFE-encoding FAM132B in patients with congenital dyserythropoietic anemia type II 72
Therapeutic targeting of Lyn kinase to treat chorea-acanthocytosis 72
Resolvin D1 and Resolvin D2 Protect Against Hypoxia/Reoxygenation Induced Lung and Kidney Damage in a Sickle Cell Mouse Model of Acute Vaso-Occlusive Crisis 71
CD66b-CD64dimCD115- cells in the human bone marrow represent neutrophil-committed progenitors 71
Data demonstrating the role of peroxiredoxin 2 as important anti-oxidant system in lung homeostasis. 70
Proteomic analysis of S-nitrosylated proteins in Arabidopsis thaliana undergoing hypersensitive response 67
Proteomic and functional analysis of tyrosinephosphorylated red cell membrane proteins in mouse lacking SRC-family-kinases 67
NCOA4 Deficiency Impairs Systemic Iron Homeostasis 66
New Therapeutic Options for the Treatment of Sickle Cell Disease. 65
Peroxiredoxin-2 (Prx2) expression is increased in beta thalassemic mouse red cells but displaced from the membrane as marker of oxidative stress 63
Pesticide toxicogenomics across scales: in vitro transcriptome predicts mechanisms and outcomes of exposure in vivo 58
Peroxiredoxin-2 plays a pivotal role as multimodal cytoprotector in the early phase of pulmonary hypertension 58
Emerging drugs in randomized controlled trials for sickle cell disease: are we on the brink of a new era in research and treatment? 56
Performance of a novel sieving matrix of Poly(vinyl alcohol)ACRYLAMIDE copolymer in elecrophoretic separations of high molecular weight proteins from red cell membrane. 55
Effects of hypoxia–reoxygenation stimuli on renal redox status and nuclear factor erythroid 2-related factor 2 pathway in sickle cell SADmice 55
The Novel Role That Nrf2 Plays in Erythropoiesis during Aging 52
Tyrosine phosphorylation modulates peroxiredoxin-2 activity in normal and diseased red cells 52
Red Blood Cell Homeostasis: Pharmacological Interventions to Explore Biochemical, Morphological and Mechanical Properties. 48
Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversible by blood transfusion 46
Bitopertin, a selective oral GLYT1 inhibitor, improves anemia in a mouse model of β-thalassemia 42
Plasma peroxiredoxin changes and inflammatory cytokines support the involvement of neuro-inflammation and oxidative stress in Autism Spectrum Disorder 38
Fyn specifically Regulates the activity of red cell glucose-6-phosphate-dehydrogenase 37
Oxidation and erythropoiesis 34
Oxidation Impacts the Intracellular Signaling Machinery in Hematological Disorders 32
Adaptative Up-Regulation of PRX2 and PRX5 Expression Characterizes Brain from a Mouse Model of Chorea-Acanthocytosis 18
Totale 3.819
Categoria #
all - tutte 10.918
article - articoli 9.192
book - libri 0
conference - conferenze 1.508
curatela - curatele 0
other - altro 218
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.836


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201942 0 0 0 0 0 0 0 0 0 7 11 24
2019/2020515 48 74 5 20 47 38 60 17 14 75 53 64
2020/2021476 57 57 12 49 43 44 17 14 13 7 54 109
2021/2022444 32 130 14 34 21 11 14 25 35 17 18 93
2022/2023983 62 132 82 150 90 240 8 37 98 33 32 19
2023/2024387 22 40 39 61 66 78 25 35 9 12 0 0
Totale 3.819